Clinical Trial Update: Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing a preventive therapy to reduce graft-versus-host disease in participants with hematologic malignancies undergoing hematopoietic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Graft-versus-host Disease
• Hematologic Malignancy
• Myelodysplastic Syndrome
• Myelomonocytic Leukemia
• T-cell Acute Lymphoblastic Leukemia

Snippet

Sponsor: Tr1X, Inc. | Conditions: Hematologic Malignancy, GvHD | Phase 1 | Status: RECRUITING